Company Filing History:
Years Active: 2025
Title: Yeabin Cho: Innovator in Cancer Treatment
Introduction
Yeabin Cho is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer research through his innovative work on antibodies. His research focuses on developing treatments that can effectively target and inhibit cancer growth.
Latest Patents
Yeabin Cho holds a patent for an "Antibody specifically binding to GRP94 or antigen-binding fragment thereof, and uses thereof." This patent describes an antibody or an antigen-binding fragment that specifically binds to GRP94. The antibody exhibits high specificity and affinity to GRP94, demonstrating excellent growth-inhibiting, infiltration-inhibiting, and angiogenesis-inhibiting effects on colorectal cancer cell lines. This innovation has the potential to be utilized as a composition for treating cancer, inhibiting cancer metastasis, and inhibiting angiogenesis.
Career Highlights
Yeabin Cho is affiliated with Kookmin University, where he continues to advance his research in the field of cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies against cancer.
Collaborations
Yeabin Cho collaborates with notable colleagues, including Sukmook Lee and Ji Woong Kim, who contribute to his research endeavors.
Conclusion
Yeabin Cho's innovative work in developing antibodies for cancer treatment highlights his commitment to advancing medical science. His contributions have the potential to significantly impact cancer therapies and improve patient outcomes.